Parkinson DiseaseEQPNCT06962930
An Online Physical Activity Coaching Intervention for People With PD in Qatar
A study testing 8-week personalized self-management program tailored to their individual needs using Engage-Qatar PD. participants will be invited to one face-to-face coaching session and 7 online sessions in people with Parkinson Disease, run by Qatar University at 3 sites in Qatar.
Trial summary
Regular exercise can improve function and quality of life as well as have other positive behavioral and health-related benefits in people Parkinson's disease (PD). Despite the benefits, insufficient exercise is common among PD individuals, often due to common barriers, emphasizing the importance of empowering… Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Parkinson Disease
- What is being tested?
- 8-week personalized self-management program tailored to their individual needs using Engage-Qatar PD. participants will be invited to one face-to-face coaching session and 7 online sessions
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 40 participants
- Where
- 3 sitesQatar
- Study dates
- 10 Sep 2025to 10 Sep 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Age above 18 years.
- Successful completion of Physical Activity Readiness Questionnaire (PAR-Q), or medical clearance from a neurologist.
- Ambulatory for indoor and outdoor mobility with or without an assistive device but without physical assistance.
- A neurologist-confirmed diagnosis of PD.
- Ability to follow study-related commands.
Who cannot join
- Musculoskeletal injury or a medical condition that would prevent safe participation in an exercise program including failure to pass the PAR-Q test.
- The presence of any other neurological conditions.
- Acute illness or injury that prevents participation in the intervention.
Trial locations and contacts
3 sites in 1 country. Contact the study team or a site near you to ask about taking part.
Qatar3 sites, 3 recruiting
- Recruiting
Qatar Rehabilitation Institution
Doha, 0000
Hanan Khalil Prof Professor, phd, +97430087097
- Recruiting
Rumaila Hospital
Doha, 0000
Hanan Khalil Prof Professor, phd, +97430087097, hkhalil@qu.edu.qa
hkhalil@qu.edu.qa
- Not yet recruiting
Qatar University
Doha, 2713
Hanan Khalil Prof Professor, phd, +974 30087097, hkhalil@qu.edu.qa
About this study
Official title: A Pilot RCT of a Remote Physical Activity Coaching Intervention to Promote Engagement in Physical Activity for People With Parkinson's Disease in Qatar
Regular exercise can improve function and quality of life as well as have other positive behavioral and health-related benefits in people Parkinson's disease (PD). Despite the benefits, insufficient exercise is common among PD individuals, often due to common barriers, emphasizing the importance of empowering individuals with adequate knowledge and self-management skills.
This project aims to develop "Engage-Qatar PD," an online physical activity self-management program for people with PD in Qatar. Engage-Qatar PD will be grounded in a previously developed coaching intervention used in people with Huntington's disease (Engage HD) and people with PD. The main focus of this project will be the development work to adapt this intervention for online delivery for people with PD and within the Qatari context.
Read more
This development stage will entail participatory design, in which users will be actively involved as co-designers to ensure fully the required cultural adaptations. Following this development phase, a pilot randomized controlled trial will be conducted to assess the feasibility, acceptability, and potential benefits of the developed intervention.
The innovative approach proposed for this project would have wide-reaching impact, advancing the development of new therapeutic options. It will deliver a realistic, culturally adapted therapeutic option for people with PD in Qatar that has the potential to be implemented in a variety of healthcare settings and other countries in the region. Importantly, future work could replicate this program in a larger cohort of individuals with other neurodegenerative diseases and extend this work to other countries in the region.
- Conditions
- Parkinson Disease
- Being tested
- 8-week personalized self-management program tailored to their individual needs using Engage-Qatar PD. participants will be invited to one face-to-face coaching session and 7 online sessions
- Keywords
- PD: Parkinson's Disease PA: Physical Activity NDD: Neuro Degenerative Disease QRI: Qatar Rehabilitation Institute
- Medical subject headings
- Parkinson Disease
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
8-week personalized self-management program tailored to their individual needs using Engage-Qatar PD. participants will be invited to one face-to-face coaching session and 7 online sessionsOther
The first session will lay the groundwork for the program, in which an orientation of the features of the online forum will be provided. In addition, goal setting, use of watches, and how to track progress will be discussed. During the remote sessions, the participant and coach will work through informational modules of how to overcome barriers to exercise engagement and how to manage PD symptoms. In addition, the coach will provide encouragement in relation to regular physical activity and exercise, and the participant will report on progress related to up to three realistic and individualized goals they developed. key elements: (1) participant-therapist interaction, (2) online forum featuring a physical activity guidebook and workbook, (3) an online platform with personal physical activity database, (4) a wearable smart watch for activity monitors, (5) a video exercise library, (6) online support group, and (7) incorporate adaptation to Arabic culture and available in Arabic
| Study group | Role | What they receive |
|---|---|---|
| intervention group | Experimental | Participants will receive an 8-week personalized self-management program. They will be invited to one to 4 face-to-face coaching sessions and 7 remote online sessions. The first session will lay the groundwork for the program, in which an orientation of the features of the online forum will be provided. In addition, goal setting, use of smart watch to record progress, and how to track progress will be discussed. During the remote sessions, the participant and coach will work through informational modules of how to overcome barriers to exercise engagement and how to manage PD symptoms. The coach will provide encouragement in relation to regular physical activity and exercise, and the participant will report on progress related to goals they developed. All participants will receive a wearable watch to help them monitor their physical activity; although wearing the watch is optional, we will recommend that all participants wear it for the 12-week intervention. Receives: Other: 8-week personalized self-management program tailored to their individual needs using Engage-Qatar PD. participants will be invited to one face-to-face coaching session and 7 online sessions |
| Control group | Active comparator | Participants in the control group will receive information on the published recommendations for physical activity for people with PD43. This is the standard information related to physical activity that an individual with PD would be expected to receive from their healthcare provider. To control for the ubiquitous nature of technology, all control participants will also receive Fitbit watches with basic instructions for monitoring their levels of physical activity. As in the intervention group, use of the Fitbit is optional, though we will recommend that both groups wear it for the 8-week intervention. The key ingredients of Engage-Qatar PD are the personalized coaching and self-management approach; thus, the control group will not have access to the Engage-Qatar PD online forum, nor will they have access to coaching or any component of the self-management approach. Receives: Other: 8-week personalized self-management program tailored to their individual needs using Engage-Qatar PD. participants will be invited to one face-to-face coaching session and 7 online sessions |
What is being measured
The primary outcome is the main question the study is designed to answer.
Objective Physical activity
7 day physical activity (i.e., moderate/vigorous activity minutes) using a waist-worn activity monitor (Actigraph)
Measured: 7 days
Secondary outcomes (21)
The Physical Activity Scale for Individuals with Physical Disabilities (PASIPD)
Modified disability version of the 10 item Physical Activity Scale for the Elderly (PASE), Captures information about leisure, household, and work-related physical activity over the preceding 7 days, Developed targeting individuals with visual/auditory and locomotor/SCI disabilities.
Measured: less than 5 minutes
International Physical Activity Questionnaire (IPAQ) short form
This measure will ask about the time spent being physically active in the last 7 days. The purpose of the questionnaires is to provide common instruments that can be used to obtain internationally comparable data on health-related physical activity.
Measured: 5 minutes
Six-Minute Walk Test (6MWT)
The 6-Minute Walk test is a measure of endurance. The Subjects will be asked to walk around the perimeter of a set circuit for a total of 6 minutes.
Measured: 10 minutes
The Short Self-Efficacy for Exercise Scale (SSEE)
is a self-report questionnaire composed of nine items for the assessment of self-efficacy for exercise
Measured: 5 minutes
8-item Parkinson's Disease Questionnaire (PDQ-8)
The 8-item version of the Parkinson's Disease Questionnaire (PDQ-8) is a shortened version of the 39-item Parkinson's Disease Questionnaire (PDQ-39). It was developed to reduce the respondent burden and increase convenience for use among persons with Parkinson's Disease in clinical settings. PDQ-39 comprises 39 questions from 8 dimensions which include mobility, activities of daily of living, emotional well-being, stigma, social support, cognition, communication, and bodily discomfort.PDQ-8 was constructed by taking one question from each domain of PDQ-39
Measured: 5-10 minutes
MDS-UPDRS-II Motor Experiences of Daily Living
The unified Parkinson's disease rating scale (UPDRS) is used to follow the longitudinal course of Parkinson's disease. The UPD rating scale is the most commonly used scale in the clinical study of Parkinson's disease. . It is consisting of 4 parts one of them is MDS-UPDRS-II Motor Experiences of Daily Living it's about motor aspects of experiences of daily living (M-EDL).
Measured: 10 minutes
MDS-UPDRS-III Motor Examination
The unified Parkinson's disease rating scale (UPDRS) is used to follow the longitudinal course of Parkinson's disease. The UPD rating scale is the most commonly used scale in the clinical study of Parkinson's disease. It is consists of 4 parts one of them is MDS-UPDRS-III Motor Examination its assesses the motor signs of PD
Measured: 15 minutes
Levodopa Equivalent Daily Doses (LEDD)
The Levodopa Equivalent Daily Dose (LEDD) is a useful calculation for comparing the doses of different Parkinson's disease medications to their equivalent amount of Levodopa. This helps clinicians to evaluate the overall dopaminergic load a patient is receiving. Various Parkinson's medications, such as Levodopa, Dopamine Agonists, and MAO-B inhibitors, can be converted into an equivalent dose of Levodopa using standard conversion factors.
Measured: 5 minutes
Mini Balance Evaluation Systems Test (Mini-BEST)
balance assessment tool is a shortened version of the Balance Evaluation Systems Test (BESTest) consists of 14 items, including 4 of the 6 sections (anticipatory postural adjustments, reactive postural control, sensory orientation, and dynamic gait) from the BESTest. It aims to target and identify 6 different balance control systems so that specific rehabilitation approaches can be designed for different balance deficits. The BESTest was shortened based on factor analysis to include dynamic balance only and to improve clinical utilization.
Measured: 10-15 minutes
Five Times Sit to Stand Test (5TSTS)
The Five Times Sit to Stand Test measures one aspect of transfer skill. The test provides a method to quantify functional lower extremity strength and identify movement strategies a patient uses to complete transitional movements.
Measured: Less than 5 minutes Depends on the number of trials
the Montréal Cognitive Assessment Scale (MOCA)
(MoCA) was designed as a rapid screening instrument for mild cognitive dysfunction. It assesses different cognitive domains: attention and concentration, executive functions, memory, language, vasoconstrictional skills, conceptual thinking, calculations, and orientation. The MoCA may be administered by anyone who understands and follows the instructions
Measured: 10 minutes
the Symbol Digit Modalities Test
a commonly used test to assess psychomotor speed, which measures processing speed as well as motor speed. requires an individual to substitute digits for abstract symbols using a reference key. Performance is also affected by attention, visual scanning and tracking, and working memory .The SDMT has excellent psychometric properties, with high reliability and validity .
Measured: less than 5 minutes
the Stroop Color-Word Interference
The Stroop Test is a measure of working memory and attention. When the colours and words a conflicting, the brain must work hard to filter out competing signals. Reading is such an automatic task that the brain needs to actively inhibit it and direct its attention instead to saying the colour of the letters. The resulting delay is called the Stroop Effect. When the colours and words match, or when the words are neutral, there is no conflicting information for the brain to have to filter out.
Measured: 5 minutes
Pittsburgh sleep quality index (PSQI)
is a self-report questionnaire that assesses sleep quality over a 1-month time interval. The measure consists of 19 individual items, creating 7 components that produce one global score It is a valuable tool for assessing sleep quality as it captures multiple dimensions of sleep, including both subjective experiences and objective parameters. It allows researchers and healthcare providers alike to obtain a comprehensive understanding of an individual's sleep patterns and disturbances.
Measured: 5-10 minutes
the Hospital Anxiety-Depression scale (HADS)
is a 14-item scale, with seven items relating to anxiety and seven relating to depression.
Measured: 2-5 minutes
10 Meter Walk Test (10MWT)
The 10 Meter Walking Test (10 MWT) assesses short duration walking speed (m/s). It has been used various patient populations including stroke, Parkinson's disease and general neurologic movement disorders.
The 10 Meter Walking Test (10 MWT) is clinician-administered, and measures the time required to walk 10 meters. The test is performed using a "flying start": the patient walks 14m, and the time is measured for the intermediate 10 meters.
Measured: 5 minutes
Barriers to Being Active Quiz (BBAQ)
is a structured questionnaire that measures the barriers to being active consists of 21 questions.
Measured: 5-10 minutes
Barriers Subscale of the Physical Fitness
It a 21-item measure assessing the following barriers to physical activity: 1) lack of time, 2) social influence, 3) lack of energy, 4) lack of willpower, 5) fear of injury, 6) lack of skill, and 7) lack of resources. Each domain contains 3 items, with a total score range of 0 to 63. Respondents rate the degree of activity interference on a 4-point scale, ranging from 0 = "very unlikely" to 3 = "very likely."
Measured: 5-10 minutes
The Modified Fatigue Impact Scale
self-report questionnaire provides an assessment of the effects of fatigue in terms of physical, cognitive, and psychosocial functioning and it consists of 21 items.
Measured: 5-10 minutes
Barriers to Health Promoting Activities for Disabled Persons Scale (BHADP)
an 18-item, 4-point scale to measure individual barriers to taking care of health. The original scale had 16 items; two additional barrier items, these items address the weather and lack of help from health care professionals. Respondents are asked to indicate how often listed barriers keep them from taking care of their health. Items include intrapersonal, interpersonal, and environmental barriers. Examples of barriers include being too tired, having other responsibilities, and lack of transportation.
Measured: 5-10 min
7 day physical activity (i.e., step count) using a waist-worn activity monitor (Actigraph)
Measured: 7 days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 May 2025
- Study start10 Sep 2025
- Primary completion10 May 2026 (estimated)
- Study completion10 Sep 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Parkinson DiseaseStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 40 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Qatar University
- Sponsor type
- University, hospital or other
- Collaborators
- Hamad Medical Corporation
- Responsible party
- Principal investigator, Hanan Khalil, Qatar University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06962930
- Sponsor's protocol ID
- QU-CG/CHS-24/25-498
- Other IDs
- QU-IRB063/2024-EA
- Acronym
- EQP
- Status last verified
- Sep 2025
- First submitted
- 30 Apr 2025
- Last updated
- 29 Sep 2025
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 29 Sep 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Pilot RCT of a Remote Physical Activity Coaching Intervention to Promote Engagement in Physical Activity for People With Parkinson's Disease in Qatar
- ClinicalTrials.gov ID
- NCT06962930
- Acronym / sponsor ID
- EQP / QU-CG/CHS-24/25-498
- Conditions
- Parkinson Disease
- Keywords
- PD: Parkinson's Disease PA: Physical Activity NDD: Neuro Degenerative Disease QRI: Qatar Rehabilitation Institute
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 40 participants (estimated)
- Lead sponsor
- Qatar UniversityUniversity, hospital or other
- Collaborators
- Hamad Medical Corporation
- Study start
- 10 Sep 2025 (actual)
- Primary completion
- 10 May 2026 (estimated)
- Study completion
- 10 Sep 2026 (estimated)
- First posted
- 8 May 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Regular exercise can improve function and quality of life as well as have other positive behavioral and health-related benefits in people Parkinson's disease (PD). Despite the benefits, insufficient exercise is common among PD individuals, often due to common barriers, emphasizing the importance of empowering individuals with adequate knowledge and self-management skills.
This project aims to develop "Engage-Qatar PD," an online physical activity self-management program for people with PD in Qatar. Engage-Qatar PD will be grounded in a previously developed coaching intervention used in people with Huntington's disease (Engage HD) and people with PD. The main focus of this project will be the development work to adapt this intervention for online delivery for people with PD and within the Qatari context.
This development stage will entail participatory design, in which users will be actively involved as co-designers to ensure fully the required cultural adaptations. Following this development phase, a pilot randomized controlled trial will be conducted to assess the feasibility, acceptability, and potential benefits of the developed intervention.
The innovative approach proposed for this project would have wide-reaching impact, advancing the development of new therapeutic options. It will deliver a realistic, culturally adapted therapeutic option for people with PD in Qatar that has the potential to be implemented in a variety of healthcare settings and other countries in the region. Importantly, future work could replicate this program in a larger cohort of individuals with other neurodegenerative diseases and extend this work to other countries in the region.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| intervention group | Experimental | Other: 8-week personalized self-management program tailored to their individual needs using Engage-Qatar PD. participants will be invited to one face-to-face coaching session and 7 online sessionsParticipants will receive an 8-week personalized self-management program. They will be invited to one to 4 face-to-face coaching sessions and 7 remote online sessions. The first session will lay the groundwork for the program, in which an orientation of the features of the online forum will be provided. In addition, goal setting, use of smart watch to record progress, and how to track progress will be discussed. During the remote sessions, the participant and coach will work through informational modules of how to overcome barriers to exercise engagement and how to manage PD symptoms. The coach will provide encouragement in relation to regular physical activity and exercise, and the participant will report on progress related to goals they developed. All participants will receive a wearable watch to help them monitor their physical activity; although wearing the watch is optional, we will recommend that all participants wear it for the 12-week intervention. |
| Control group | Active comparator | Other: 8-week personalized self-management program tailored to their individual needs using Engage-Qatar PD. participants will be invited to one face-to-face coaching session and 7 online sessionsParticipants in the control group will receive information on the published recommendations for physical activity for people with PD43. This is the standard information related to physical activity that an individual with PD would be expected to receive from their healthcare provider. To control for the ubiquitous nature of technology, all control participants will also receive Fitbit watches with basic instructions for monitoring their levels of physical activity. As in the intervention group, use of the Fitbit is optional, though we will recommend that both groups wear it for the 8-week intervention. The key ingredients of Engage-Qatar PD are the personalized coaching and self-management approach; thus, the control group will not have access to the Engage-Qatar PD online forum, nor will they have access to coaching or any component of the self-management approach. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- Age above 18 years.
- Successful completion of Physical Activity Readiness Questionnaire (PAR-Q), or medical clearance from a neurologist.
- Ambulatory for indoor and outdoor mobility with or without an assistive device but without physical assistance.
- A neurologist-confirmed diagnosis of PD.
- Ability to follow study-related commands.
Key exclusion criteria (3 listed)
- Musculoskeletal injury or a medical condition that would prevent safe participation in an exercise program including failure to pass the PAR-Q test.
- The presence of any other neurological conditions.
- Acute illness or injury that prevents participation in the intervention.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| 8-week personalized self-management program tailored to their individual needs using Engage-Qatar PD. participants will be invited to one face-to-face coaching session and 7 online sessionsThe first session will lay the groundwork for the program, in which an orientation of the features of the online forum will be provided. In addition, goal setting, use of watches, and how to track progress will be discussed. During the remote sessions, the participant and coach will work through informational modules of how to overcome barriers to exercise engagement and how to manage PD symptoms. In addition, the coach will provide encouragement in relation to regular physical activity and exercise, and the participant will report on progress related to up to three realistic and individualized goals they developed. key elements: (1) participant-therapist interaction, (2) online forum featuring a physical activity guidebook and workbook, (3) an online platform with personal physical activity database, (4) a wearable smart watch for activity monitors, (5) a video exercise library, (6) online support group, and (7) incorporate adaptation to Arabic culture and available in Arabic | Other | Control group, intervention group |
Primary outcome
Objective Physical activity
Time frame: 7 days
7 day physical activity (i.e., moderate/vigorous activity minutes) using a waist-worn activity monitor (Actigraph)
21 secondary outcomes
The Physical Activity Scale for Individuals with Physical Disabilities (PASIPD)
Time frame: less than 5 minutes
International Physical Activity Questionnaire (IPAQ) short form
Time frame: 5 minutes
Six-Minute Walk Test (6MWT)
Time frame: 10 minutes
The Short Self-Efficacy for Exercise Scale (SSEE)
Time frame: 5 minutes
8-item Parkinson's Disease Questionnaire (PDQ-8)
Time frame: 5-10 minutes
MDS-UPDRS-II Motor Experiences of Daily Living
Time frame: 10 minutes
MDS-UPDRS-III Motor Examination
Time frame: 15 minutes
Levodopa Equivalent Daily Doses (LEDD)
Time frame: 5 minutes
Mini Balance Evaluation Systems Test (Mini-BEST)
Time frame: 10-15 minutes
Five Times Sit to Stand Test (5TSTS)
Time frame: Less than 5 minutes Depends on the number of trials
the Montréal Cognitive Assessment Scale (MOCA)
Time frame: 10 minutes
the Symbol Digit Modalities Test
Time frame: less than 5 minutes
the Stroop Color-Word Interference
Time frame: 5 minutes
Pittsburgh sleep quality index (PSQI)
Time frame: 5-10 minutes
the Hospital Anxiety-Depression scale (HADS)
Time frame: 2-5 minutes
10 Meter Walk Test (10MWT)
Time frame: 5 minutes
Barriers to Being Active Quiz (BBAQ)
Time frame: 5-10 minutes
Barriers Subscale of the Physical Fitness
Time frame: 5-10 minutes
The Modified Fatigue Impact Scale
Time frame: 5-10 minutes
Barriers to Health Promoting Activities for Disabled Persons Scale (BHADP)
Time frame: 5-10 min
7 day physical activity (i.e., step count) using a waist-worn activity monitor (Actigraph)
Time frame: 7 days
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 29 Sep 2025.
- Individual participant dataSharing planned: No
Related trials for Parkinson Disease
Not yet recruiting
Comparative Effects of Virtual Reality and Proprioceptive Neuromuscular Facilitation in Patients With Parkinson's Disease
Parkinson Disease
Active, not recruiting
Myrosinase Bioactivated Gglucoraphanin for the Treatment of Neurodegenerative Diseases (GRA-MYR-ND)
PARKINSON DISEASE (Disorder), Multiple Sclerosis (MS) - Relapsing-remitting
RecruitingPhase 1
Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease Patients
Parkinson Disease, Parkinson's Disease
Not yet recruitingObservational study
Longitudinal Observation of Neurodegeneration in Parkinson's Disease Using Molecular Imaging and Blood Biomarkers
Idiopathic Parkinson Disease
Active, not recruitingPhase 2
A Study of Botensilimab and Balstilimab for the Treatment of Colorectal Cancer
Metastatic Colorectal Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
3 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing 8-week personalized self-management program tailored to their individual needs using Engage-Qatar PD. participants will be invited to one face-to-face coaching session and 7 online sessions in people with Parkinson Disease, run by Qatar University at 3 sites in Qatar.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 29 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 3 sites in Qatar. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Hanan Khalil prof Professor, phd (+974 30087097, hkhalil@qu.edu.qa), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Objective Physical activity (time frame: 7 days). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Sep 2025.